| scholarly article | Q13442814 |
| P2093 | author name string | Mandip Singh | |
| Punit P Shah | |||
| Pinaki R Desai | |||
| Debra Channer | |||
| P2860 | cites work | Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends | Q30463832 |
| Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002. | Q30997838 | ||
| Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs | Q33186805 | ||
| Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: characterization of viscosity, in vitro drug release, droplet size, and dynamic surface tension | Q33231485 | ||
| Insights into synergistic interactions in binary mixtures of chemical permeation enhancers for transdermal drug delivery | Q33255445 | ||
| Follicular transport route--research progress and future perspectives | Q33388072 | ||
| Translocation of cell penetrating peptide engrafted nanoparticles across skin layers | Q33562478 | ||
| Influence of microneedle shape on the transport of a fluorescent dye into human skin in vivo. | Q33637958 | ||
| Drug delivery into the skin by degradable particles | Q33860608 | ||
| Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer | Q34014392 | ||
| Penetratin-induced transdermal delivery from H(II) mesophases of sodium diclofenac | Q34150945 | ||
| Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery | Q34700358 | ||
| Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer | Q34982543 | ||
| Membrane-permeable arginine-rich peptides and the translocation mechanisms | Q36049556 | ||
| Lipid nanoparticles for improved topical application of drugs for skin diseases | Q36838029 | ||
| Cosmetic features and applications of lipid nanoparticles (SLN, NLC). | Q37152869 | ||
| In vitro and in vivo evaluation of topical formulations of spantide II. | Q37360916 | ||
| Recent advances in the use of cell-penetrating peptides for medical and biological applications | Q37524585 | ||
| Nanotechnology and the transdermal route: A state of the art review and critical appraisal | Q37619773 | ||
| Cell entry of cell penetrating peptides: tales of tails wagging dogs | Q38003743 | ||
| Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice | Q38455697 | ||
| Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs | Q39897426 | ||
| Development and evaluation of sustained release gastroretentive minimatrices for effective treatment of H. pylori infection | Q41989264 | ||
| Design and optimization of mefloquine hydrochloride microparticles for bitter taste masking | Q41989651 | ||
| Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen | Q42183286 | ||
| Magnetophoresis for enhancing transdermal drug delivery: Mechanistic studies and patch design. | Q42380872 | ||
| Comparison of the efficacy of tacrolimus and cyclosporine A in a murine model of dinitrofluorobenzene-induced atopic dermatitis | Q42950693 | ||
| Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis | Q42967569 | ||
| H(II) mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac | Q43147290 | ||
| Sodium diclofenac and cell-penetrating peptides embedded in H(II) mesophases: physical characterization and delivery | Q43938359 | ||
| Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. | Q43982806 | ||
| Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance | Q44125997 | ||
| The influence of various methods of cold storage of skin on the permeation of melatonin and nimesulide | Q44254794 | ||
| Physical and thermal characterisation of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets | Q44485967 | ||
| Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis | Q44578444 | ||
| Preformulation stability of Spantide II, a promising topical anti-inflammatory agent for the treatment of psoriasis and contact dermatitis | Q44773914 | ||
| Percutaneous absorption and anti-inflammatory effect of a substance P receptor antagonist: spantide II. | Q44776602 | ||
| Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin. | Q45990071 | ||
| Nanoparticle coated submicron emulsions: sustained in-vitro release and improved dermal delivery of all-trans-retinol | Q46041573 | ||
| Design and optimization of artemether microparticles for bitter taste masking | Q46185866 | ||
| Influence of chitosan crosslinking on bitterness of mefloquine hydrochloride microparticles using central composite design | Q46532192 | ||
| Effect of chitosan crosslinking on bitterness of artemether using response surface methodology | Q46670579 | ||
| Stability and degradation profiles of Spantide II in aqueous solutions | Q46788161 | ||
| Investigations on factors affecting chitosan for dissolution enhancement of oxcarbazepine by spray dried microcrystal formulation with an experimental design approach | Q46984694 | ||
| Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation. | Q51508006 | ||
| Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex. | Q51537837 | ||
| In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin | Q61801747 | ||
| Involvement of substance P as a mediator in capsaicin-induced mouse ear oedema | Q70992664 | ||
| Polyarginine enters cells more efficiently than other polycationic homopolymers | Q73233590 | ||
| A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis | Q79743481 | ||
| Noninvasive and efficient transdermal delivery of CpG-oligodeoxynucleotide for cancer immunotherapy | Q83268054 | ||
| Microdialysis assessment of percutaneous penetration of ketoprofen after transdermal administration to hairless rats and domestic pigs | Q83598572 | ||
| A fast screening strategy for characterizing peptide delivery by transdermal iontophoresis | Q83615099 | ||
| Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers | Q84072308 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 735-745 | |
| P577 | publication date | 2012-05-14 | |
| P1433 | published in | Journal of Controlled Release | Q6295046 |
| P1476 | title | Enhanced skin permeation using polyarginine modified nanostructured lipid carriers | |
| P478 | volume | 161 |
| Q34736361 | (31)P solid-state NMR based monitoring of permeation of cell penetrating peptides into skin |
| Q89909527 | A systematic in vitro investigation on poly-arginine modified nanostructured lipid carrier: Pharmaceutical characteristics, cellular uptake, mechanisms and cytotoxicity |
| Q61805268 | An efficient and long-acting local anesthetic: ropivacaine-loaded lipid-polymer hybrid nanoparticles for the control of pain |
| Q56035513 | Basic considerations in the dermatokinetics of topical formulations |
| Q47098090 | Breaking the Barrier - Potent Anti-Inflammatory Activity following Efficient Topical Delivery of Etanercept using Thermoresponsive Nanogels. |
| Q33734460 | Capsaicin-loaded nanolipoidal carriers for topical application: design, characterization, and in vitro/in vivo evaluation |
| Q38030731 | Cell-penetrating peptides as a novel transdermal drug delivery system |
| Q36109341 | Cyclic Dipeptide Shuttles as a Novel Skin Penetration Enhancement Approach: Preliminary Evaluation with Diclofenac |
| Q57073301 | Deepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicines |
| Q36176209 | Dermal microdialysis technique to evaluate the trafficking of surface-modified lipid nanoparticles upon topical application |
| Q42731716 | Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers |
| Q35772168 | Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers |
| Q53092152 | Effect of combination of hydrophilic and lipophilic permeation enhancers on the skin permeation of kahalalide F. |
| Q54991276 | Engineering nanoparticles to overcome barriers to immunotherapy. |
| Q47738254 | Functionalised nanostructures for transdermal delivery of drug cargos |
| Q53667150 | How can lipid nanocarriers improve transdermal delivery of olanzapine? |
| Q37141351 | Investigation of follicular and non-follicular pathways for polyarginine and oleic acid-modified nanoparticles |
| Q38260735 | Nanomedicine strategies for targeting skin inflammation. |
| Q28542908 | Nanomiemgel--a novel drug delivery system for topical application--in vitro and in vivo evaluation |
| Q38195310 | Nanoparticles as multifunctional devices for the topical treatment of cutaneous leishmaniasis |
| Q36641553 | Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma |
| Q53655387 | Percutaneous delivery of α-melanocyte-stimulating hormone for the treatment of imiquimod-induced psoriasis. |
| Q50072089 | Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery |
| Q37134733 | Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin |
| Q39014253 | Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application. |
| Q94540538 | Skin Delivery of siRNA Using Sponge Spicules in Combination with Cationic Flexible Liposomes |
| Q39450103 | Stratum corneum modulation by chemical enhancers and lipid nanostructures: implications for transdermal drug delivery |
| Q28071773 | Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses |
| Q35989535 | Systemic Administration of siRNA via cRGD-containing Peptide |
| Q38104407 | Therapeutic potential of cell-penetrating peptides. |
| Q30432272 | Topical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo |
| Q47444826 | Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy |
| Q37727325 | Ultra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention |
| Q92824512 | pH-Responsive Polypeptide-Based Smart Nano-Carriers for Theranostic Applications |
Search more.